Clinical Trial Update: Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anlotinib with concurrent chemoradiotherapy for locally advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer | Phase 2 | Status: UNKNOWN